期刊文献+

铜绿假单胞菌医院感染与耐药性分析 被引量:27

Nosocomial Infection with Pseudomonas aeruginosa and Approach of Drug-resistance:A Clinical Overview
下载PDF
导出
摘要 目的探讨铜绿假单胞菌(PAE)医院感染的耐药性,为医院感染的监测与控制提供依据。方法采用美国MicroScan WalkAway-40细菌鉴定仪将PAE进行鉴定,并采用K-B纸片扩散法进行体外耐药监测及统计耐药率。结果2年中检出325株PAE,其中对耐亚胺培南铜绿假单胞菌(IRPA)占总株数的14.8%;PAE分离率最高的病区为重症监护病房(ICU),占20.9%;其次为老年病科,占19.4%;第3为呼吸内科,占16.9%;IRPA对11种常用抗菌药物的耐药率明显高于非耐药株,IRPA除对头孢他啶、头孢吡肟、氨曲南等3种抗菌药物耐药率均<50.0%外,对其余8种抗菌药物耐药率均>50.0%。结论PAE的耐药性已十分严重,必须进行严密的监控,预防PAE导致的医院感染暴发流行。 OBJECTIVE To investigate nosocomial infection and drug-resistance of Pseudomonasaeruginosa (PAE) in our hospital to provide the evidence for clinical monitoring and control of nosocomial infection. METHODS The microbiological system MicroScan WalkAway-40 was used to identify PAE and the drug-resistance in vitro was determined by K-B methods. RESULTS Among 325 strains of PAE in two years, imipenem-resistant P. aeruginosa (IRPA) accounted for 14.8%. The highest isolating rates occurred in the intensive care unit (ICU), accounted for 20.9%. The following was senile disease department, accounted for 19.4%. The respiratory department rated the third, accounted for 16. 9%. The resistance of IRPA to 11 kinds of common antibiotics was significantly higher than imipenem-sensitive P. aeruginosa (ISPA). Except the drug-resistance of IRPA to ceftazidime, cefepime and aztreonam was below 50.0%, that to the other eight antibiotics was all over 50.0%. CONCLUSIONS The drug-resistance of PAE is very serious in our hosptial. We should perform rigorous monitoring and prevent the outbreak of nosocomial infection with PAE.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第12期1781-1783,共3页 Chinese Journal of Nosocomiology
关键词 医院感染 铜绿假单胞菌 耐药性 Nosocomial infection Pseudornonasaeruginosa Drug-resistance
  • 相关文献

参考文献6

二级参考文献43

  • 1蒋晓飞,倪语星.铜绿假单胞菌产生的超广谱β-内酰胺酶[J].中华微生物学和免疫学杂志,2001,21(S1):10-12. 被引量:10
  • 2糜祖煌.铜绿假单胞菌耐药基因及其检测[J].现代实用医学,2004,16(9):558-560. 被引量:47
  • 3许宏涛,陈东科,俞云松,张秀珍.多重耐药铜绿假单胞菌产β-内酰胺酶耐药机制研究[J].中华医院感染学杂志,2005,15(1):20-22. 被引量:81
  • 4李智山,邓三季,杨燕,赵建忠.铜绿假单胞菌氨基糖苷类修饰酶基因分子流行病学研究[J].中华医院感染学杂志,2005,15(2):134-136. 被引量:21
  • 5Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000,38(1): 40-43.
  • 6Pal H, Lyu S, Lee JH, et al. Survey of extended-spectrum be-ta-lactamases in clinical isolates of Escherichia coli and Kleb-siella pneumoniae, prevalence of TEM-52 in Korea[J]. J Clin Microbiol, 1999, 37(6): 1758-1763.
  • 7Coudron PE, Moland ES, Thomson KS. Occurrence and de-tection of AmpC beta-lactamases among Eseheriehia eoli,Klebsiella pneumoniae, and Proteus mirabilis isolates at a vet-erans medical center[J]. J Clin Microbiol, 2000, 38(5): 1791-1796.
  • 8Sabath LD, Abraham EP. Zinc as a cofactor for cephalospori-nase from Bacillus cereus 569[J]. Biochem J, 1966, 98(1):11c-13c.
  • 9Naas T, Poirel L, Xarim A, et al. Molecular characterization of In 50, a class 1 integron encoding the genes for the extend-ed-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa [J]. TEMS Microbiol Lett, 1999, 176(2): 411-419.
  • 10Lauretti L, Riccio ML, Mazzariol A, et al. Cloning and characterization of bla VIM, a new integron-borne metallo-β-lacta-mase gene from a Pseudomonas aeruginosa clinical isolate [J]-Antimicrob Agents Chemother, 1999, 43(7): 1584-1590.

共引文献225

同被引文献148

引证文献27

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部